[go: up one dir, main page]

GB9927698D0 - Therapeutic antibody - Google Patents

Therapeutic antibody

Info

Publication number
GB9927698D0
GB9927698D0 GBGB9927698.2A GB9927698A GB9927698D0 GB 9927698 D0 GB9927698 D0 GB 9927698D0 GB 9927698 A GB9927698 A GB 9927698A GB 9927698 D0 GB9927698 D0 GB 9927698D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic antibody
antibody
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9927698.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9927698.2A priority Critical patent/GB9927698D0/en
Publication of GB9927698D0 publication Critical patent/GB9927698D0/en
Priority to PL00350993A priority patent/PL350993A1/en
Priority to PCT/EP2000/001455 priority patent/WO2000050460A1/en
Priority to CZ20013082A priority patent/CZ20013082A3/en
Priority to JP2000601038A priority patent/JP2004538238A/en
Priority to BR0008963-0A priority patent/BR0008963A/en
Priority to MXPA01008613A priority patent/MXPA01008613A/en
Priority to KR1020017010939A priority patent/KR20020007313A/en
Priority to NZ513679A priority patent/NZ513679A/en
Priority to HU0200049A priority patent/HUP0200049A2/en
Priority to CA002363637A priority patent/CA2363637A1/en
Priority to TR2001/02506T priority patent/TR200102506T2/en
Priority to AU26727/00A priority patent/AU2672700A/en
Priority to HK02103724.5A priority patent/HK1044004A1/en
Priority to EP00905073A priority patent/EP1155037A1/en
Priority to CN00806614A priority patent/CN1348466A/en
Priority to IL14502400A priority patent/IL145024A0/en
Priority to CO00013394A priority patent/CO5210906A1/en
Priority to ARP000100820A priority patent/AR029336A1/en
Priority to NO20014130A priority patent/NO20014130L/en
Priority to US10/304,443 priority patent/US20030170229A1/en
Priority to US11/005,794 priority patent/US20050214285A1/en
Ceased legal-status Critical Current

Links

GBGB9927698.2A 1999-02-25 1999-11-23 Therapeutic antibody Ceased GB9927698D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB9927698.2A GB9927698D0 (en) 1999-11-23 1999-11-23 Therapeutic antibody
IL14502400A IL145024A0 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
CA002363637A CA2363637A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
AU26727/00A AU2672700A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
CZ20013082A CZ20013082A3 (en) 1999-02-25 2000-02-22 Peptide
JP2000601038A JP2004538238A (en) 1999-02-25 2000-02-22 Epitope or mimotope derived from the C-epsilon-2 domain of IgE, antagonists and therapeutic uses thereof
BR0008963-0A BR0008963A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the ige dec-epsilon-2 domain, antagonists thereof, and their therapeutic uses
MXPA01008613A MXPA01008613A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses.
KR1020017010939A KR20020007313A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
NZ513679A NZ513679A (en) 1999-02-25 2000-02-22 Epitodes or mimotopes derived from the C-epsilon-2 domain of IgE, antagonists thereof, and their therapeutic uses
HU0200049A HUP0200049A2 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
PL00350993A PL350993A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
TR2001/02506T TR200102506T2 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from Ige's C-epsilon-2 domain
PCT/EP2000/001455 WO2000050460A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
HK02103724.5A HK1044004A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
EP00905073A EP1155037A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses
CN00806614A CN1348466A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses
ARP000100820A AR029336A1 (en) 1999-02-25 2000-02-25 USEFUL PEPTIDES TO PREPARE MEDICINES FOR THE TREATMENT, PREVENTION OR IMPROVEMENT OF ALLERGIC STATES, IMMUNOGENS, EPITHOPES AND MIMOTOPES, VACCINES, LIGENDS, PHARMACEUTICAL COMPOSITIONS; USE OF THE PEPTIDES, OF THE LIGANDS IN THE PREPARATION OF MEDICINES; PROCESS TO PREPARE VACCINES AND PR
CO00013394A CO5210906A1 (en) 1999-02-25 2000-02-25 IMUNOGENS CONTAINING PEPTIDES FROM DOMINO CE2 DE IgE FOR THE TREATMENT AND PREVENTION OF ALLERGIC DISEASES
NO20014130A NO20014130L (en) 1999-02-25 2001-08-24 Epitopes or mimotopes derived from the C <epsilon> 2 domain of IgE, its antagonists and their therapeutic uses
US10/304,443 US20030170229A1 (en) 1999-02-25 2002-11-26 Vaccine
US11/005,794 US20050214285A1 (en) 1999-03-29 2004-12-07 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9927698.2A GB9927698D0 (en) 1999-11-23 1999-11-23 Therapeutic antibody

Publications (1)

Publication Number Publication Date
GB9927698D0 true GB9927698D0 (en) 2000-01-19

Family

ID=10865006

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9927698.2A Ceased GB9927698D0 (en) 1999-02-25 1999-11-23 Therapeutic antibody

Country Status (1)

Country Link
GB (1) GB9927698D0 (en)

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
GB9911569D0 (en) Antibodies
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9907243D0 (en) Therapy
GB9930570D0 (en) Therapy
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9911802D0 (en) Therapeutic combination
GB9929569D0 (en) Therapeutic agents
GB9911803D0 (en) Therapeutic combination
GB9914745D0 (en) Therapeutic agents
GB9911804D0 (en) Therapeutic combination
GB9914744D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
IL147078A0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
GB9915419D0 (en) Antigens
GB9914743D0 (en) Therapeutic agents
GB9927698D0 (en) Therapeutic antibody
GB9915616D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)